Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fink

Showing results (231-240 of 363) with videos related to

Pageof 37
Sort By:
The Lancet. Psychiatry|June 28, 2017
Imipramine for multiple functional somatic syndromes - Authors' replyJohanne L Agger, Andreas Schröder, Lise K Gormsen, et al.
Physical Review Letters|April 12, 2003
Stabilization of polar ZnO surfaces: validating microscopic models by using CO as a probe moleculeV Staemmler, K Fink, B Meyer, et al.
Hepatology (Baltimore, Md.)|February 3, 2000
Treatment of Wilson's disease with zinc. XVII: treatment during pregnancyG J Brewer, V D Johnson, R D Dick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumorsC I Civin, N Dorfman, A Eggers, et al.
Neurology|June 1, 1996
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working groupJ K Fink, T Heiman-Patterson, T Bird, et al.
Journal of Medical Genetics|November 6, 2001
Hereditary spastic paraplegia linked to chromosome 14q11-q21: reduction of the SPG3 locus interval from 5.3 to 2.7 cMS Rainier, P Hedera, D Alvarado, et al.
American Journal of Human Genetics|February 11, 1999
Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8qP Hedera, S Rainier, D Alvarado, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 3, 2019
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysisMark V Pinti, Garrett K Fink, Quincy A Hathaway, et al.
The Lancet. Psychiatry|April 15, 2017
Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised studyJohanne L Agger, Andreas Schröder, Lise K Gormsen, et al.
Archives of Neurology|October 1, 1996
Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapyG J Brewer, V Johnson, R D Dick, et al.
Pageof 37

Showing results (231-240 of 363) with videos related to

Sort By:
Pageof 37
The Lancet. Psychiatry|June 28, 2017
Imipramine for multiple functional somatic syndromes - Authors' replyJohanne L Agger, Andreas Schröder, Lise K Gormsen, et al.
Physical Review Letters|April 12, 2003
Stabilization of polar ZnO surfaces: validating microscopic models by using CO as a probe moleculeV Staemmler, K Fink, B Meyer, et al.
Hepatology (Baltimore, Md.)|February 3, 2000
Treatment of Wilson's disease with zinc. XVII: treatment during pregnancyG J Brewer, V D Johnson, R D Dick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumorsC I Civin, N Dorfman, A Eggers, et al.
Neurology|June 1, 1996
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working groupJ K Fink, T Heiman-Patterson, T Bird, et al.
Journal of Medical Genetics|November 6, 2001
Hereditary spastic paraplegia linked to chromosome 14q11-q21: reduction of the SPG3 locus interval from 5.3 to 2.7 cMS Rainier, P Hedera, D Alvarado, et al.
American Journal of Human Genetics|February 11, 1999
Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8qP Hedera, S Rainier, D Alvarado, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 3, 2019
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysisMark V Pinti, Garrett K Fink, Quincy A Hathaway, et al.
The Lancet. Psychiatry|April 15, 2017
Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised studyJohanne L Agger, Andreas Schröder, Lise K Gormsen, et al.
Archives of Neurology|October 1, 1996
Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapyG J Brewer, V Johnson, R D Dick, et al.
Pageof 37